CorMedix (CRMD) Cash & Current Investments (2016 - 2025)
CorMedix has reported Cash & Current Investments over the past 16 years, most recently at $155.2 million for Q4 2025.
- Quarterly results put Cash & Current Investments at $155.2 million for Q4 2025, up 200.27% from a year ago — trailing twelve months through Dec 2025 was $155.2 million (up 200.27% YoY), and the annual figure for FY2025 was $155.2 million, up 200.27%.
- Cash & Current Investments reached $155.2 million in Q4 2025 per CRMD's latest filing, up from $55.7 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $190.7 million in Q2 2025 and bottomed at $19.8 million in Q2 2023.
- Median Cash & Current Investments over the past 5 years was $55.7 million (2023), compared with a mean of $66.3 million.
- The largest annual shift saw Cash & Current Investments surged 342.79% in 2021 before it crashed 68.91% in 2022.
- Over 5 years, Cash & Current Investments stood at $53.4 million in 2021, then fell by 19.04% to $43.3 million in 2022, then rose by 1.03% to $43.7 million in 2023, then increased by 18.22% to $51.7 million in 2024, then skyrocketed by 200.27% to $155.2 million in 2025.
- Business Quant data shows Cash & Current Investments for CRMD at $155.2 million in Q4 2025, $55.7 million in Q3 2025, and $190.7 million in Q2 2025.